Monopar Therapeutics
MNPR
MNPR
12 hedge funds and large institutions have $310K invested in Monopar Therapeutics in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$34.4K | |
| 2 | +$14.1K | |
| 3 | +$1.44K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$704 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$47 |
Top Sellers
| 1 | -$21K | |
| 2 | -$3.75K | |
| 3 | -$3.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.75K |
| 5 |
Morgan Stanley
New York
|
-$545 |